LAGOSTA is a Swiss blue biotech company, expert in biomedical chitosan production.
Issue
Chitosan has multiple biotech applications yet to benefit patients for the sole reason that reproducible chitosan is not available.
Solution
By farming European spiny lobsters - Palinurus elephas - in our state-of-the-art indoor fully controlled facility, our approach, enables:
- 5x faster growth than in the wild
- an exclusive, naturally generated, stable raw material: molts (byproducts)
- no seasonal variations of the raw material
- full traceability
This unique raw material & our process produce a cGMP biomedical chitosan with:
- Reproducible biological properties
- High molecular weight > 400 kDa
- High degree of deacetylation DDA>95%
- Compliant with EU and US pharmacopoeia standards
No news
18.10.2022
Production of the 1st reproducible biomedical chitosan batch
No Jobs
LAGOSTA
No Awards
Website:
lagosta.com/
Headquarter:
St-Prex
Foundation Date:
February 2013
Technology: